StockMarketWire.com - JP Morgan Cazenove today reaffirms its overweight investment rating on Circassia Pharmaceuticals Plc Ord 0.08p [LON:CIR] and cut its price target to 170p (from 410p).

Story provided by StockMarketWire.com